← Ecosystem map
Rea Diagnostics SA
Diagnostics company developing an at-home self-test for pregnant women to assess preterm birth risk.
At a glance
- What it offers
- Diagnostics / Diagnostic Test
- Primary health focus
- Pregnancy
- Who it supports
- Patients and Consumers, Healthcare Professionals, Researchers
- Company stage
- Pilot / Validation
About
Rea's lead test combines a self-collected vaginal swab with a paper-strip immunoassay, without a reader or electronics. Its research builds on biosensor engineering at EPFL and includes work on biomarker detection in self-collected samples.
Need addressed
Access to preterm birth risk testing without a hospital visit or clinician-led sample collection.
Organisation’s contribution
Engineering sampling and biomarker detection methods for use outside hospital settings.
Women’s health focus
Product & development
- Clinical stage
- The lead test is undergoing clinical validation at Lausanne University Hospital (CHUV), in collaboration with its obstetrics department.